The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: A retrospective study

AIDS Research and Therapy

Volumn 9, Issue , 2012, Pages

  Berhe, Tesfaye ^a   Melkamu, Yilma ^a   Amare, Amanuel ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Africa; Antiretroviral therapy; Cryptococcus; Opportunistic infection; Toxoplasmosis; Tuberculosis

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CEFTRIAXONE; COTRIMOXAZOLE; ETHAMBUTOL; FLUCONAZOLE; GENTAMICIN; ISONIAZID; PENICILLIN G; PHENYTOIN; PYRAZINAMIDE; PYRIDOXINE; PYRIMETHAMINE PLUS SULFADOXINE; RIFAMPICIN; STREPTOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL MENINGITIS; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM TUMOR; CRYPTOCOCCAL MENINGITIS; ETHIOPIA; FATALITY; FEMALE; GLASGOW COMA SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SEIZURE; SENSORY SYSTEM; TOXOPLASMOSIS; TUBERCULOUS MENINGITIS;

EID: 84859498865     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-9-11     Document Type: Article

References (20)

1. Weisberg LA. Neurologic abnormalities in human immunodeficiency virus infection. South Med J 2001, 94:266-275.
2. Levy RM, Bredesen DE. Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988, 1:41-64.
3. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994, 121:769-785.
4. Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS 1999, 13:1677-85. 10.1097/00002030-199909100-00011, 10509569.
5. Almeida SM, Ribeiro CE, Pessa LC, Moreira SD, Vidal LR, Nogueira MB, Raboni SM. Incidence of neurological manifestations as AIDS defining clinical conditions in Brazil. BMC Proc 2008, 2(Suppl I):45.
6. Bhigjee AI, Naidoo K, Patel VB, Govender D. Intracranial mass lesions in HIVpostive patients-the KwaZulu/Natal experience. Neuroscience AIDS Research Group S Afr Med J 1999, 89:1284-8.
7. Fragoso YD, Mendes V, Adamo AM, Bosco LP, Tavares CF. Neurologic manifestations of AIDS: a review of fifty cases in Santos, Brazil. Sao Paulo Med J 1998, 116:1715-1720.
8. Isezuo SA, Sani AZ, Ezunu E, Maiyaki S, Njoku CH, Obembe A. Clinical neuropathy in HIV/AIDS: an eight-year review of hospitalized patients in Sokoto, northwestern Nigeria. Trop Doct 2009, 39:133-35. 10.1258/td.2008.080313, 19535744.
9. Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. Q J Med 2004, 97:413-21.
10. Ogun SA, Ojini FI, Okubadejo N, Danesi M, Kolapo K, Osalusi B, Boyle B. Pattern and outcome of Neurological manifestations of HIV/AIDS-a review of 154 cases in a Nigerian University Teaching Hospital- A preliminary report. Afr J Neuro Sci 2005, 24:29-36.
11. Satishchandra P, Nalini A, Gourie-devi M, Khanna N, Santosh V, Ravi V, Chandramuki AD, Jayakumar PN, Shankar SK. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res 2000, 111:14-23.
12. Satya AV, Kumar GA, Pratap SV, Vivekananda VD, Madhukar R, Shyam S. Neurological manifestations of HIV- infected patients around Varanasi, India. Afr J Neuro Sci 2006, 25:33-40.
13. FMOH of Ethiopia Implementation guidelines for TB/HIV collaborative Activities in Ethiopia. 2008, 2-3. FMOH of Ethiopia.
14. WHO case definitions of HIV for Surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007, 10-38.
15. Chhin S, Rozycki G, Pugatch D, Harwell JI. Aetiology of meningitis in HIV-infected patients in a referral hospital in Phnom Penh, Cambodia. Int J STD AIDS 2004, 15:48-50. 10.1258/095646204322637263, 14769172.
16. Perriens JH, Mussa M, Luabeya MK, Kayembe K, Kapita B, Brown C, Piot P, Janssen R. Neurological complications of HIV-1-Seropositive Internal Medicine Inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr 1992, 5:333-340.
17. Portegies P, Enting RH, Gans J, Algra PR, Derix MA, Lange JA, Goudsmit J. Presentation and course of AIDS dementia complex:10 years of follow-up in Amsterdam, The Netherlands. AIDS 1993, 7:669-75. 10.1097/00002030-199305000-00010, 8318174.
18. Tsegaye A, Messele T, Tilahun T, Hailu E, Sahlu T, Doorly R, Fontanet AL, Rinke de Wit TF. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999, 6(3):410-414. 103732, 10225845.
19. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology, 1985 to 1999; rising prevalence of HIV encephalopathy in the Era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002, 31:171-177. 10.1097/00126334-200210010-00007, 12394795.
20. Karstaedt AS, Valtchanova S, Barriere R, Crewe-brown HH. Tuberculous meningitis in South African urban Adults. Q J Med 1998, 91:743-747.